Explore All Access
Check if your research matches the topics covered in Current Hematologic Malignancy Reports?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Hematologic Malignancy Reports : Impact Factor & More
eISSN: 1558-822XpISSN: 1558-8211
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Hematologic Malignancy Reports Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
H-Index
40
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.27
Topics Covered on Current Hematologic Malignancy Reports
B-cell lymphoma
Immunotherapy
Minimal residual disease
Monoclonal antibody
Diffuse large B-cell lymphoma
Toxicity
Chimeric antigen receptor
Hematopoietic stem cell transplantation
Cell therapy
Bispecific antibody
Hematology clinic
Chemoimmunotherapy
Chronic myelomonocytic leukemia
Bortezomib
Social media
T-cell lymphoma
Immune system
Myelofibrosis
Target antigen
Toxicity profile
Current Hematologic Malignancy Reports Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CURRENT MEDICINE GROUP |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Hematologic Malignancy Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Hematologic Malignancy Reports
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease.
- 9 Nov 2024
- Current hematologic malignancy reports
Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas.
- 19 Oct 2024
- Current hematologic malignancy reports
JAK Inhibitors for Myelofibrosis: Strengths and Limitations.
- 14 Oct 2024
- Current hematologic malignancy reports
Advances in Stem Cell Transplantation for Myelofibrosis.
- 6 Sep 2024
- Current hematologic malignancy reports
Systemic Mastocytosis: State of the Art.
- 27 Aug 2024
- Current hematologic malignancy reports
Prognostic and Predictive Models in Myelofibrosis
- 24 Aug 2024
- Current Hematologic Malignancy Reports
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease.
- 9 Nov 2024
- Current hematologic malignancy reports
Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas.
- 19 Oct 2024
- Current hematologic malignancy reports
JAK Inhibitors for Myelofibrosis: Strengths and Limitations.
- 14 Oct 2024
- Current hematologic malignancy reports
Advances in Stem Cell Transplantation for Myelofibrosis.
- 6 Sep 2024
- Current hematologic malignancy reports
Systemic Mastocytosis: State of the Art.
- 27 Aug 2024
- Current hematologic malignancy reports
Prognostic and Predictive Models in Myelofibrosis
- 24 Aug 2024
- Current Hematologic Malignancy Reports
Compare Similar Journals with Current Hematologic Malignancy Reports
Select Journals to Compare with Current Hematologic Malignancy Reports
Total journals - 8
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Blood advances
Publisher: ELSEVIER
Cancers
Publisher: MDPI
British Journal of Haematology
Publisher: WILEY
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Leukemia
Publisher: SPRINGERNATURE
0 Journals Selected to compare with
Current Hematologic Malignancy Reports
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Hematologic Malignancy Reports
How long has Current Hematologic Malignancy Reports been actively publishing? 
Current Hematologic Malignancy Reports has been in operation since 2005 till date.
What is the publishing frequency of Current Hematologic Malignancy Reports?
Current Hematologic Malignancy Reports published with a Quarterly frequency.
How many articles did Current Hematologic Malignancy Reports publish last year?
In 2023, Current Hematologic Malignancy Reports publsihed 35 articles.
What is the eISSN & pISSN for Current Hematologic Malignancy Reports?
For Current Hematologic Malignancy Reports, eISSN is 1558-822X and pISSN is 1558-8211.
What is Citescore for Current Hematologic Malignancy Reports?
Citescore for Current Hematologic Malignancy Reports is 6.5.
What is the H Index for Current Hematologic Malignancy Reports ?
H Index for Current Hematologic Malignancy Reports is 40.
What is SNIP score for Current Hematologic Malignancy Reports?
SNIP score for Current Hematologic Malignancy Reports is 1.27.
What is the SJR for Current Hematologic Malignancy Reports?
SJR for Current Hematologic Malignancy Reports is Q2.
Who is the publisher of Current Hematologic Malignancy Reports?
CURRENT MEDICINE GROUP is the publisher of Current Hematologic Malignancy Reports.
